Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 2: Hematologic, cutaneous and vascular syndromes

Lung Cancer. 2017 Apr:106:93-101. doi: 10.1016/j.lungcan.2017.01.016. Epub 2017 Jan 30.

Abstract

The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes associated with lung cancer appears useful. This article is the second of a series of five and deals with hematologic, cutaneous and vascular syndromes.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Autoimmune Diseases / chemically induced*
  • Carcinoma, Non-Small-Cell Lung / complications
  • Female
  • Hematologic Diseases / complications
  • Hematologic Diseases / therapy
  • Humans
  • Immunotherapy / adverse effects
  • Lung Neoplasms / complications*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Paraneoplastic Syndromes / chemically induced
  • Paraneoplastic Syndromes / immunology*
  • Skin Diseases / complications
  • Skin Diseases / immunology
  • Skin Diseases / therapy
  • Vascular Diseases / complications
  • Vascular Diseases / immunology
  • Vascular Diseases / therapy